Animal Dissections

Zygmunt Dembek sounds a false alarm in his letter about the value of alternatives to animal dissection in the training of veterinarians, medical doctors, and other medical professionals (Letters, The Scientist, 12[1]:10, Jan. 5, 1998). He would have readers believe that students who have shunned animal dissection in favor of computer simulations and other alternative training methods are unprepared to work on real patients, while implying that students who have dissected dead or anesthetized an

Written byJonathan Balcombe
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In truth, neither group is prepared. It is only when students begin to work with patients in the clinical setting (as interns and residents, then as "practicing" professionals) that they truly gain proficiency in their skills.

To appreciate the diminishing role of animal dissections in medical training, consider that, according to the Physicians Committee for Responsible Medicine, half of the 126 medical schools in the United States today have no animal labs whatsoever, and only one of the remaining 63 schools considers them mandatory. Also, at least 18 schools of veterinary medicine in the U.S. and Canada have alternative programs, in which students may learn their trade in a more ethically sensitive and usually clinically focused setting. There is no evidence to suggest that these students' education is compromised. In fact, one can argue that the sort of compassion that motivates their choice of learning methods makes them exemplary candidates ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies